Reflections on the Fate of Cerebral Embolic Protection Devices With TAVR: The REFLECT II Trial

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
11 Downloads (Pure)
Original languageEnglish
Pages (from-to)528-530
Number of pages3
JournalJACC: Cardiovascular Interventions
Issue number5
Publication statusPublished - 8 Mar 2021

Bibliographical note

Funding Information:
Dr. Van Mieghem has received institutional research grant support from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Medtronic, Daiichi-Sankyo, PulseCath BV, and Abiomed. Dr. Daemen has received institutional grant/research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical, and ReCor medical.

Research programs

  • EMC COEUR-09

Cite this